Star Pharmaceutical Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Star Pharmaceutical Limited with three other
pharmaceutical manufacturers in Asia:
Traphaco High Tech Joint Stock Co
sales of 318.19 billion Dong [US$13.65 million]
Bioalpha Holdings Bhd
(55.92 million Malaysian Ringgits [US$13.62 million]
Nutraplus India Ltd
based in India
(914.19 million Indian Rupees [US$13.07 million]
During the year ended December of 2017, sales at
Star Pharmaceutical Limited were 93.32 million Chinese Renmimbi (US$13.46 million).
increase of 51.3%
versus 2016, when the company's sales were 61.68 million Chinese Renmimbi.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Star Pharmaceutical Limited had sales
of 87.82 million Chinese Renmimbi.